Institutional investors hold a majority ownership of NBIX through the 78.10% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2013, these large investors purchased a net $1.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORBIMED ADVISORS LLC Bought 2.1 Million shares of Neurocrine Biosciences In...
DEUTSCHE ASSET & WEALTH MANAGEME... Bought 988.0 Thousand shares of Neurocrine Biosciences In...